AstraZeneca Ups Betting Ante On Moderna's Messenger RNA Technology

Emboldened by results from their existing alliance on mRNA drugs for cardiovascular, metabolic and regenerative disease, AstraZeneca PLC and privately held Moderna Therapeutics LLC have decided to extend their focus to include candidates for the treatment of a range of cancers.